Diagnosis requires a combination of clinical performance, imaging, laboratory testing, and pathological activation. A platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Individual development of treatments for treatment and management of congenital myeloma usually includes drug therapy, rehabilitation intervention, and regular follow-up to multiple-dimensional management.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of congenital myeloma.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.